Nuo Therapeutics, Inc. filed its 10-K on Apr 15, 2022 for the period ending Dec 31, 2021. In this report its auditor, Marcum LLP, gave an unqualified opinion expressing doubt that the company can continue as a going concern.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.75 USD | 0.00% | -6.25% | +36.36% |
04-19 | Nuo Therapeutics, Inc. Reports Earnings Results for the Full Year Ended December 31, 2023 | CI |
03-19 | Exor-backed NUO invests in Italian teenage clothing chain Subdued | RE |
1st Jan change | Capi. | |
---|---|---|
+36.36% | 33.18M | |
+9.58% | 115B | |
+12.41% | 106B | |
-2.59% | 21.96B | |
-12.38% | 21.87B | |
-5.29% | 19.21B | |
-3.35% | 18.08B | |
-38.57% | 17.71B | |
+7.51% | 14.32B | |
+35.67% | 12.42B |
- Stock Market
- Equities
- AURX Stock
- News Nuo Therapeutics, Inc.
- Nuo Therapeutics, Inc. Auditor Raises 'Going Concern' Doubt